Three unreported cases of TMEM199-CDG, a rare genetic liver disease with abnormal glycosylation
Abstract Background TMEM199 deficiency was recently shown in four patients to cause liver disease with steatosis, elevated serum transaminases, cholesterol and alkaline phosphatase and abnormal protein glycosylation. There is no information on the long-term outcome in this disorder. Results We here...
Main Authors: | Pietro Vajro, Katarzyna Zielinska, Bobby G. Ng, Marco Maccarana, Per Bengtson, Marco Poeta, Claudia Mandato, Elisa D’Acunto, Hudson H. Freeze, Erik A. Eklund |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-01-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13023-017-0757-3 |
Similar Items
-
Clinical and Molecular Characterization of ALG1-CDG
by: Radhika Dhamija, et al.
Published: (2016-04-01) -
Spontaneous improvement of carbohydrate-deficient transferrin in PMM2-CDG without mannose observed in CDG natural history study
by: Peter Witters, et al.
Published: (2021-02-01) -
ALG9-CDG: New clinical case and review of the literature
by: Kellie Davis, et al.
Published: (2017-12-01) -
New Insights into Immunological Involvement in Congenital Disorders of Glycosylation (CDG) from a People-Centric Approach
by: Rita Francisco, et al.
Published: (2020-07-01) -
ALG3-CDG: a patient with novel variants and review of the genetic and ophthalmic findings
by: Martina Farolfi, et al.
Published: (2021-06-01)